Health CanadaType I
Pharmascience PMS-Losartan product recall (2021-10-13)
Published: October 13, 2021Recall ID: RA-76645Category: generalCountry: Canada
Product Description & Identification
Pharmascience PMS-Losartan product recall (2021-10-13)
Additional Source Details
| Field | Value |
|---|---|
| Panels › 1 › Text | <b>Issue:</b> Product Safety<BR/><b>Audience:</b> General Public, Healthcare Professionals, Hospitals<BR/><b>Category:</b> Drugs<BR/><b>Alert type:</b> Drug Recall<BR/><b>Department:</b> Health Canada<BR/><b>Hazard classification:</b> Type I<BR/> |
| Panels › 1 › Title | Summary |
| Panels › 1 › Panel Name | basic_details |
| Panels › 2 › Text | <b>Product: </b>A. PMS-Losartan 25mg B. PMS-Losartan 50mg C. PMS-Losartan 100mg<BR/> |
| Panels › 2 › Title | Summary |
| Panels › 2 › Panel Name | summary |
| Panels › 3 › Text | <p> A. PMS-Losartan 25mg</p> <p> B. PMS-Losartan 50mg</p> <p> C. PMS-Losartan 100mg</p> |
| Panels › 3 › Title | Introduction |
| Panels › 3 › Panel Name | intro_text |
| Panels › 4 › Text | Presence of impurity (5-[4'-[(5-(Azidomethyl)-2-butyl-4-chloro-1H-imidazol-1-yl)methyl]-[1,1'-biphenyl]-2-yl]-1H-tetrazole) above the acceptable concentration limit in affected lots |
| Panels › 4 › Title | Reason |
| Panels › 4 › Panel Name | cms_reason_reason_recall |
| Panels › 5 › Text | Retailers |
| Panels › 5 › Title | Depth of distribution |
| Panels › 5 › Panel Name | cms_reason_depth_distribution |
| Panels › 6 › Text | <b>Brand name:</b> A. PMS-Losartan 25mg<br/><b>Dosage form:</b> Tablet <BR/><b>Strength:</b> Losartan Potassium 25mg<BR/><b>DIN, NPN, DIN-HIM:</b> DIN 02309750<BR/><b>Lot or serial number:</b> 629303, 636356<BR/><b>Companies:</b><br/><dl><dt>Recalling Firm</dt><dd>Pharmascience Inc.</dd><dd>6111 Royalmount Avenue</dd><dd>Montreal </dd><dd>H4P 2T4</dd><dd>CANADA</dd></dl><dl><dt>Marketing Authorization Holder</dt><dd>Pharmascience Inc.</dd><dd>6111 Royalmount Avenue</dd><dd>Montreal </dd><dd>H4P 2T4</dd><dd>CANADA</dd></dl> |
| Panels › 6 › Title | A. PMS-Losartan 25mg |
| Panels › 6 › Panel Name | product_1 |
| Panels › 7 › Text | <b>Brand name:</b> B. PMS-Losartan 50mg<br/><b>Dosage form:</b> Tablet <BR/><b>Strength:</b> Losartan Potassium 50mg<BR/><b>DIN, NPN, DIN-HIM:</b> DIN 02309769<BR/><b>Lot or serial number:</b> 629302, 636348, 636357<BR/><b>Companies:</b><br/><dl><dt>Recalling Firm</dt><dd>Pharmascience Inc.</dd><dd>6111 Royalmount Avenue</dd><dd>Montreal </dd><dd>H4P 2T4</dd><dd>CANADA</dd></dl><dl><dt>Marketing Authorization Holder</dt><dd>Pharmascience Inc.</dd><dd>6111 Royalmount Avenue</dd><dd>Montreal </dd><dd>H4P 2T4</dd><dd>CANADA</dd></dl> |
| Panels › 7 › Title | B. PMS-Losartan 50mg |
| Panels › 7 › Panel Name | product_2 |
| Panels › 8 › Text | <b>Brand name:</b> C. PMS-Losartan 100mg<br/><b>Dosage form:</b> Tablet <BR/><b>Strength:</b> Losartan Potassium 100mg<BR/><b>DIN, NPN, DIN-HIM:</b> DIN 02309777<BR/><b>Lot or serial number:</b> 629306, 629307,636346,636358<BR/><b>Companies:</b><br/><dl><dt>Recalling Firm</dt><dd>Pharmascience Inc.</dd><dd>6111 Royalmount Avenue</dd><dd>Montreal </dd><dd>H4P 2T4</dd><dd>CANADA</dd></dl><dl><dt>Marketing Authorization Holder</dt><dd>Pharmascience Inc.</dd><dd>6111 Royalmount Avenue</dd><dd>Montreal </dd><dd>H4P 2T4</dd><dd>CANADA</dd></dl> |
| Panels › 8 › Title | C. PMS-Losartan 100mg |
| Panels › 8 › Panel Name | product_3 |
| Panels › 9 › Text | <a href="https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2021/75715a-eng.php">https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2021/75715a-eng.php</a> |
| Panels › 9 › Title | For more information |
| Panels › 9 › Panel Name | more_information |
| Panels › 10 › Text | <b>Identification number:</b> RA-76645<BR/> |
| Panels › 10 › Title | Identification number |
| Panels › 10 › Panel Name | id_numbers |
| Recall Id | RA-76645 |
| Start date | 1634083200 |
| Date published | -62169984000 |